- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AXSM
Recent news which mentions AXSM
12 Top Stocks to Buy in December
December 03, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 30, 2022
From Benzinga
Axsome Therapeutics's Return On Capital Employed Insights
November 30, 2022
Tickers
AXSM
From Benzinga
From Benzinga
Tesla, Apple, Anavex, Axsome, Pinduoduo: Why These 5 Stocks Are Drawing Investors' Attention Today
November 28, 2022
From Benzinga
What to know about the Alzheimer’s drug data coming out this week
November 28, 2022
From MarketWatch
Dow Tumbles 450 Points; S&P 500 Falls 1.5%
November 28, 2022
From Benzinga
10 Things to Know as Tesla Revamps Model 3 With Project ‘Highland’
November 28, 2022
From InvestorPlace
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
November 28, 2022
From Benzinga
Swvl Layoffs 2022: What to Know About the Latest SWVL Job Cuts
November 28, 2022
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
November 28, 2022
From Benzinga
Why Is Axsome Therapeutics (AXSM) Stock Up 32% Today?
November 28, 2022
From InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
November 28, 2022
From Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $13,000 Today
November 28, 2022
Tickers
AXSM
From Benzinga
Dow Tumbles Over 200 Points; Axsome Therapeutics Shares Spike Higher
November 28, 2022
From Benzinga
US Stocks Start Week On Lower Note, Dow Drops Over 100 Points
November 28, 2022
From Benzinga
Analyst Says Coinbase 'A Waste Of Time', Taylor Swift's Concert Fiasco Under DOJ Probe, Shopify Clocks Record Black Friday Sales: Top Stories Monday, Nov. 28
November 28, 2022
From Benzinga
Axsome Therapeutics Investigational Drug Lowers Risk Of Agitation Relapse In Alzheimer's Patients
November 28, 2022
Tickers
AXSM
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 28, 2022
From Benzinga
Want to Double Your Money? Buying These Stocks Could be a Genius Move
November 28, 2022
From Motley Fool
3 Growth Stocks to Buy That Could Skyrocket
November 28, 2022
From Motley Fool
Prediction: This Growth Stock Could Double in 2023
November 24, 2022
From Motley Fool
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
November 20, 2022
From Motley Fool
These 3 Stocks Are Crushing the Market. Wall Street Thinks They Can Soar at Least 78% Higher.
November 18, 2022
From Motley Fool
Is Axsome Therapeutics Stock a Buy Now?
November 11, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.